Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06SJO
|
|||
| Former ID |
DIB014866
|
|||
| Drug Name |
GSK-2282512A
|
|||
| Synonyms |
FLU Q-QIV; GSK-2604409A; Quadrivalent inactivated split virion vaccine (im, seasonal influenza virus infection); Quadrivalent inactivated split virion vaccine (im, seasonal influenza virus infection), GlaxoSmithKline
Click to Show/Hide
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 3 | [1], [2] | |
| Company |
GlaxoSmithKline Biologicals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01204671) Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A). U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01711736) Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.